Xtant Medical Holdings (XTNT) Profit After Tax Growth (3y) (2013 - 2025)
Xtant Medical Holdings (XTNT) Profit After Tax Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | -12.28% |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 20.02% |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 1.93% |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 49.66% |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | -7.65% |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | 29.05% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 9.79% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 97.37% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 15.46% |
| 10 | Xtant Medical Holdings | 46.30 Mn | 28.69 Mn | 17.75 Mn | 26.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 29.44% |
| Sep 30, 2025 | 36.72% |
| Jun 30, 2025 | 59.74% |
| Mar 31, 2025 | 26.54% |
| Dec 31, 2024 | -15.42% |
| Sep 30, 2024 | -40.69% |
| Jun 30, 2024 | -73.99% |
| Mar 31, 2024 | -433.36% |
| Dec 31, 2023 | -82.67% |
| Sep 30, 2023 | 106.36% |
| Jun 30, 2023 | 3.85% |
| Mar 31, 2023 | 5.89% |
| Dec 31, 2022 | -11.23% |
| Sep 30, 2022 | -7.79% |
| Jun 30, 2022 | 4.10% |
| Mar 31, 2022 | 7.53% |
| Dec 31, 2021 | 65.72% |
| Sep 30, 2021 | 16.98% |
| Jun 30, 2021 | 47.28% |
| Mar 31, 2021 | 82.33% |